Catherine Bergeron, MD - Publications

Affiliations: 
Laboratory Medicine and Pathobiology University of Toronto, Toronto, ON, Canada 
Area:
neuropathology of human neurodegenerative diseases
Website:
http://www.utoronto.ca/crnd/research.htm#Bergeron

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lukiw WJ, Kruck TPA, Percy ME, Pogue AI, Alexandrov PN, Walsh WJ, Sharfman NM, Jaber VR, Zhao Y, Li W, Bergeron C, Culicchia F, Fang Z, McLachlan DRC. Aluminum in neurological disease - a 36 year multicenter study. Journal of Alzheimer's Disease & Parkinsonism. 8. PMID 31179161 DOI: 10.4172/2161-0460.1000457  0.35
2019 McLachlan DRC, Bergeron C, Alexandrov PN, Walsh WJ, Pogue AI, Percy ME, Kruck TPA, Fang Z, Sharfman NM, Jaber V, Zhao Y, Li W, Lukiw WJ. Aluminum in Neurological and Neurodegenerative Disease. Molecular Neurobiology. PMID 30706368 DOI: 10.1007/S12035-018-1441-X  0.325
2009 Hazrati LN, Bergeron C, Butany J. Neuropathology of cerebrovascular diseases. Seminars in Diagnostic Pathology. 26: 103-15. PMID 19891304 DOI: 10.1053/J.Semdp.2009.08.002  0.316
2008 Hazrati LN, Bergeron C. Neuropathology and genetics of corticobasal degeneration. Handbook of Clinical Neurology. 89: 523-32. PMID 18631774 DOI: 10.1016/S0072-9752(07)01248-1  0.354
2006 Espay AJ, Bergeron C, Chen R, Lang AE. Rapidly progressive sporadic dentatorubral pallidoluysian atrophy with intracytoplasmic inclusions and no CAG repeat expansion. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 2251-4. PMID 17078058 DOI: 10.1002/Mds.21158  0.312
2006 Murakami T, Paitel E, Kawarabayashi T, Ikeda M, Chishti MA, Janus C, Matsubara E, Sasaki A, Kawarai T, Phinney AL, Harigaya Y, Horne P, Egashira N, Mishima K, Hanna A, ... ... Bergeron C, et al. Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation. The American Journal of Pathology. 169: 1365-75. PMID 17003492 DOI: 10.2353/Ajpath.2006.051250  0.358
2006 Bergeron C, Davis A, Lang AE. Corticobasal Ganglionic Degeneration and Progressive Supranuclear Palsy Presenting with Cognitive Decline Brain Pathology. 8: 355-365. PMID 9546292 DOI: 10.1111/J.1750-3639.1998.Tb00159.X  0.364
2004 Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. The American Journal of Pathology. 165: 523-31. PMID 15277226 DOI: 10.1016/S0002-9440(10)63317-2  0.328
2003 Rogaeva E, Bergeron C, Sato C, Moliaka I, Kawarai T, Toulina A, Song YQ, Kolesnikova T, Orlacchio A, Bernardi G, St George-Hyslop PH. PS1 Alzheimer's disease family with spastic paraplegia: the search for a gene modifier. Neurology. 61: 1005-7. PMID 14557582 DOI: 10.1212/Wnl.61.7.1005  0.339
2003 Phinney AL, Horne P, Yang J, Janus C, Bergeron C, Westaway D. Mouse models of Alzheimer's disease: the long and filamentous road. Neurological Research. 25: 590-600. PMID 14503012 DOI: 10.1179/016164103101202020  0.363
2003 Munoz DG, Dickson DW, Bergeron C, Mackenzie IR, Delacourte A, Zhukareva V. The neuropathology and biochemistry of frontotemporal dementia. Annals of Neurology. 54: S24-8. PMID 12833365 DOI: 10.1002/Ana.10571  0.308
2002 Achim C, Auer R, Bergeron C, Cardozo A, Deprez M, de Vos R, Duyckaerts C, Egensperger R, Esiri M, Frosch MP, Giannini C, Goebel HH, Graeber MB, Graham DI, Gray F, et al. Global democratic consensus on neuropathological disease criteria. The Lancet. Neurology. 1: 340. PMID 12849392 DOI: 10.1016/S1474-4422(02)00156-4  0.302
2002 Rozmahel R, Mount HT, Chen F, Nguyen V, Huang J, Erdebil S, Liauw J, Yu G, Hasegawa H, Gu Y, Song YQ, Schmidt SD, Nixon RA, Mathews PM, Bergeron C, et al. Alleles at the Nicastrin locus modify presenilin 1- deficiency phenotype. Proceedings of the National Academy of Sciences of the United States of America. 99: 14452-7. PMID 12388777 DOI: 10.1073/Pnas.222413999  0.302
2002 Morris HR, Baker M, Yasojima K, Houlden H, Khan MN, Wood NW, Hardy J, Grossman M, Trojanowski J, Revesz T, Bigio EH, Bergeron C, Janssen JC, McGeer PL, Rossor MN, et al. Analysis of tau haplotypes in Pick's disease. Neurology. 59: 443-5. PMID 12177383 DOI: 10.1212/Wnl.59.3.443  0.338
2002 Forman MS, Zhukareva V, Bergeron C, Chin SS, Grossman M, Clark C, Lee VM, Trojanowski JQ. Signature tau neuropathology in gray and white matter of corticobasal degeneration. The American Journal of Pathology. 160: 2045-53. PMID 12057909 DOI: 10.1016/S0002-9440(10)61154-6  0.348
2002 Westaway D, Janus C, Johnson H, Chishti MA, McLaurin J, Mathews P, Jiang Y, Schmidt SD, Horne P, French J, Nixon RA, Mercken M, Fraser PE, Bergeron C, Carlson GA, et al. Aβ-immunization reduces learning impairment and amyloid plaque burden in an animal model of Alzheimer's disease European Neuropsychopharmacology. 12: 98. DOI: 10.1016/S0924-977X(02)80030-X  0.321
2001 Schmidt ML, Schuck T, Sheridan S, Kung MP, Kung H, Zhuang ZP, Bergeron C, Lamarche JS, Skovronsky D, Giasson BI, Lee VM, Trojanowski JQ. The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains. The American Journal of Pathology. 159: 937-43. PMID 11549586 DOI: 10.1016/S0002-9440(10)61769-5  0.342
2001 Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, ... ... Bergeron C, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 56: 1702-6. PMID 11425937 DOI: 10.1212/Wnl.56.12.1702  0.312
2001 Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, ... ... Bergeron C, et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. The Journal of Biological Chemistry. 276: 21562-70. PMID 11279122 DOI: 10.1074/Jbc.M100710200  0.335
2001 Yu WH, Lukiw WJ, Bergeron C, Niznik HB, Fraser PE. Metallothionein III is reduced in Alzheimer's disease. Brain Research. 894: 37-45. PMID 11245813 DOI: 10.1016/S0006-8993(00)03196-6  0.343
2000 Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408: 979-82. PMID 11140685 DOI: 10.1038/35050110  0.301
2000 Grimes DA, Lang AE, Bergeron C. Late adult onset chorea with typical pathology of Hallervorden-Spatz syndrome Journal of Neurology, Neurosurgery, and Psychiatry. 69: 392-395. PMID 10945817 DOI: 10.1136/Jnnp.69.3.392  0.311
2000 LeBlanc AC, Akerman BR, Zhang Y, Cynthia G, Bergeron C. Caspases, amyloid metabolism and Alzheimer's disease Neurobiology of Aging. 21: 136-137. DOI: 10.1016/S0197-4580(00)82413-6  0.328
1996 Bergeron C, Pollanen MS, Weyer L, Black SE, Lang AE. Unusual clinical presentations of cortical-basal ganglionic degeneration. Annals of Neurology. 40: 893-900. PMID 9007094 DOI: 10.1002/Ana.410400611  0.327
1996 McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47: 1113-24. PMID 8909416 DOI: 10.1212/Wnl.47.5.1113  0.384
1996 Lippa CF, Saunders AM, Smith TW, Swearer JM, Drachman DA, Ghetti B, Nee L, Pulaski-Salo D, Dickson D, Robitaille Y, Bergeron C, Crain B, Benson MD, Farlow M, Hyman BT, et al. Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology. 46: 406-12. PMID 8614503 DOI: 10.1212/Wnl.46.2.406  0.366
1996 Kalra S, Bergeron C, Lang AE. Lewy body disease and dementia. A review. Jama Internal Medicine. 156: 487-493. DOI: 10.1001/Archinte.1996.00440050031004  0.402
1995 Pollanen MS, Weyer L, Bergeron C. Distribution Of Phosphorylated Tau In PickʼS Disease, Corticobasal Degeneration, And Frontal Lobe Dementia: 142 Journal of Neuropathology and Experimental Neurology. 54: 446. DOI: 10.1097/00005072-199505000-00158  0.338
1994 Lang AE, Bergeron C, Pollanen MS, Ashby P. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology. 44: 1436-40. PMID 8058145 DOI: 10.1212/Wnl.44.8.1436  0.336
1993 Sutherland MK, Wong L, Somerville MJ, Yoong LK, Bergeron C, Parmentier M, McLachlan DR. Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus. Brain Research. Molecular Brain Research. 18: 32-42. PMID 8479289 DOI: 10.1016/0169-328X(93)90171-K  0.305
1993 Morrison LD, Bergeron C, Kish SJ. Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease Neuroscience Letters. 154: 141-144. PMID 8361629 DOI: 10.1016/0304-3940(93)90191-M  0.351
1993 Pollanen MS, Bergeron C, Weyer L. Absence of protease-resistant prion protein in dementia characterized by neuronal loss and status spongiosus Acta Neuropathologica. 86: 515-517. PMID 8310801 DOI: 10.1007/Bf00228588  0.337
1993 Mastrogiacomo F, Bergeron C, Kish SJ. Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease Journal of Neurochemistry. 61: 2007-2014. PMID 8245957 DOI: 10.1111/J.1471-4159.1993.Tb07436.X  0.326
1992 Karlinsky H, Madrick E, Ridgley J, Berg JM, Becker R, Bergeron C, Hodgkinson S, Percy ME, McLachlan D. A family with multiple instances of definite, probable and possible early-onset Alzheimer's disease. The British Journal of Psychiatry : the Journal of Mental Science. 159: 524-30. PMID 1751863 DOI: 10.1192/Bjp.159.4.524  0.339
1992 Lukiw WJ, Krishnan B, Wong L, Kruck TP, Bergeron C, Crapper McLachlan DR. Nuclear compartmentalization of aluminum in Alzheimer's disease (AD). Neurobiology of Aging. 13: 115-21. PMID 1542372 DOI: 10.1016/0197-4580(92)90018-S  0.339
1992 Karlinsky H, Vaula G, Haines JL, Ridgley J, Bergeron C, Mortilla M, Tupler RG, Percy ME, Robitaille Y, Noldy NE. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the beta-amyloid precursor protein gene. Neurology. 42: 1445-53. PMID 1520398 DOI: 10.1212/Wnl.42.8.1445  0.33
1992 Sutherland MK, Wong L, Somerville MJ, Handley P, Yoong L, Bergeron C, McLachlan DRC. Reduction of thyroid hormone receptor c-ERB Aα mRNA levels in the hippocampus of Alzheimer as compared to huntington brain Neurobiology of Aging. 13: 301-312. PMID 1387923 DOI: 10.1016/0197-4580(92)90043-W  0.322
1992 Pollanen MS, Bergeron C, Weyer L. Detergent‐Insoluble Cortical Lewy Body Fibrils Share Epitopes with Neurofilament and τ Journal of Neurochemistry. 58: 1953-1956. PMID 1373181 DOI: 10.1111/J.1471-4159.1992.Tb10074.X  0.337
1992 Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM, Nobrega JN. Brain cytochrome oxidase in Alzheimer's disease. Journal of Neurochemistry. 59: 776-9. PMID 1321237 DOI: 10.1111/J.1471-4159.1992.Tb09439.X  0.347
1988 McLachlan DR, Lukiw WJ, Wong L, Bergeron C, Bech-Hansen NT. Selective messenger RNA reduction in Alzheimer's disease. Brain Research. 427: 255-61. PMID 3401702 DOI: 10.1016/0169-328X(88)90048-4  0.325
1988 McLachlan DR, Wong L, Bergeron C, Baimbridge KG. Calmodulin and calbindin D28K in Alzheimer disease. Alzheimer Disease and Associated Disorders. 1: 171-9. PMID 2840101 DOI: 10.1097/00002093-198701030-00009  0.364
1987 Perry TL, Yong VW, Bergeron C, Hansen S, Jones K. Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease. Annals of Neurology. 21: 331-6. PMID 3579218 DOI: 10.1002/Ana.410210403  0.354
1985 Davis PH, Bergeron C, McLachlan DR. Atypical presentation of progressive supranuclear palsy. Annals of Neurology. 17: 337-343. PMID 4004154 DOI: 10.1002/Ana.410170406  0.32
1984 McLachlan DR, Lewis PN, Lukiw WJ, Sima A, Bergeron C, De Boni U. Chromatin structure in dementia. Annals of Neurology. 15: 329-34. PMID 6742779 DOI: 10.1002/Ana.410150405  0.356
Show low-probability matches.